Corcept Therapeutics
United States
243 articles about Corcept Therapeutics
-
After yesterday's big plunge in the stock market, and today with the Dow Jones Industrial Average dropping more than 500 points after opening, but mostly recovering, volatility appears to be the key word to describe the stock market.
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
2/1/2018
The company’s preliminary fourth quarter revenue was $53.3 million, compared to $23.8 million in the fourth quarter of 2016.
-
A look at two life science companies that are expected to grow more than 67 percent over the next five years.
-
Corcept Therapeutics Announces Third Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update
11/3/2017
Third quarter revenue of $42.8 million, an increase of 97 percent from third quarter 2016.
-
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
10/27/2017
The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
-
When you think about it, most small biotech companies are odd investments.
-
Corcept Therapeutics Inc. Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance And Provides Corporate Update
8/2/2017
-
Corcept Therapeutics Inc. To Announce Second Quarter Financial Results, Provide Corporate Update And Host Conference Call
7/26/2017
-
Corcept Therapeutics Inc. Announces Presentations On Mifepristone For The Treatment Of Patients With Hypercortisolism At American Association of Clinical Endocrinologists 26th Annual Congress
5/4/2017
-
Corcept Therapeutics Inc. Announces First Quarter 2017 Financial Results, Raises 2017 Revenue Guidance And Provides Corporate Update
5/3/2017
-
Corcept Therapeutics Inc. To Announce First Quarter Financial Results And Corporate Update And Host Conference Call
4/26/2017
-
Corcept Therapeutics Inc. Announces Fourth Quarter And Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance
3/7/2017
-
Corcept Therapeutics Inc. Announces Preliminary Fourth Quarter And Full-Year 2016 Financial Results And Corporate Update; Provides 2017 Revenue Guidance
1/31/2017
-
Corcept Therapeutics Inc. Release: PharmaTo Announce Preliminary 2016 Financial Results, Provide 2017 Revenue Guidance And Corporate Update, And Host Conference Call
1/24/2017
-
Corcept Therapeutics Inc. Announces Encouraging Results Of Phase 1/2 Trial Of Mifepristone Plus Eribulin In Triple-Negative Breast Cancer
12/12/2016
-
Corcept Therapeutics Inc. Announces Third Quarter 2016 Financial Results And Provides Corporate Update
11/2/2016
-
Corcept Therapeutics Inc. To Announce Third Quarter 2016 Financial Results And Corporate Update And Host Conference Call
10/27/2016
-
Corcept Therapeutics Inc. Announces Second Quarter 2016 Financial Results And Provides Corporate Update
8/3/2016
-
Corcept Therapeutics Inc. To Announce Second Quarter 2016 Financial Results And Corporate Update And Host Conference Call
7/27/2016
-
Corcept Therapeutics Inc. Appoints Renee D. Gala To Board Of Directors
6/29/2016